The carrier, as it sends a US-bound vessel through the region, said if security thresholds hold it will take a “stepwise approach” toward gradually resuming navigation on east-west services via the Suez Canal and Red Sea.
Continue reading →
Ganni has named three execs amid the Danish label’s global growth while Freightos founder and CEO Zvi Schreiber begins succession process.
Continue reading →
Union Pacific sent a 6,000-plus page application to US regulators Friday seeking formal approval for its closely watched merger proposal with Norfolk Southern that would create the country’s first transcontinental railroad.
Continue reading →
The moves come as capacity from Asia to the East and West coasts of South America has risen sharply this year, and as Mexico plans hefty tariffs against China.
Continue reading →
Ford Motor Co. will lay off about 1,500 workers in Kentucky as it converts its Glendale plant from electric vehicle batteries to energy storage.
Continue reading →
On this episode of the This Week in Cleantech podcast, Dana Clare Redden from our “Cleantecher of the Year” committee announces our “Cleantechers of the Year.”
Continue reading →
In some respects, AI is reinventing the very act of pharmaceutical research. Across leading biopharma companies, the image of the “bench scientist” is vanishing, replaced by a “Researcher 2.0” who spends more time training algorithms and curating datasets than mixing...
David Ratcliff, MD, is stepping down as chief medical officer of Fayetteville, Ark.-based Washington Regional Medical Center after 22 years in the role.During his tenure, Dr. Ratcliff oversaw the development of key service lines and helped launch a graduate medical education program. He will...
About 350 registered nurses, as well as radiology technicians, at Henry Ford Rochester (Mich.) Hospital have ratified new labor agreements with Detroit-based Henry Ford Health. Here are five things to know: 1. Members of Office and Professional Employees International Union Local 40 voted Dec....
The pharmaceutical industry heads into 2026 carrying strong M&A momentum, a surging Chinese deal landscape and continued buzz around obesity drugs and new modalities. Deals involving Chinese pharma and biotech firms reached $92.2 billion in potential value through November 2025....